Literature DB >> 21238427

Effects of single nucleotide changes on the binding and activity of RNA aptamers to human papillomavirus 16 E7 oncoprotein.

Clare Nicol1, David H J Bunka, G Eric Blair, Nicola J Stonehouse.   

Abstract

A virally-encoded oncoprotein (E7 from human papillomavirus 16, involved in the initiation of cell transformation) was the target for RNA aptamer development by the process of systematic evolution of ligands by exponential enrichment (SELEX). A number of aptamers were identified, one of which was shown to inhibit the interaction between E7 and its major binding partner, pRb. Aptamers with very similar sequences (more than 92% similarity in the random regions) did not share this activity. This study demonstrates the potential of aptamers to be highly specific, with small differences in aptamer sequence having profound effects on function.
Copyright © 2011 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21238427     DOI: 10.1016/j.bbrc.2011.01.044

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN: 0006-291X            Impact factor:   3.575


  9 in total

1.  Characterization of an RNA aptamer against HPV-16 L1 virus-like particles.

Authors:  Ana Gabriela Leija-Montoya; María Luisa Benítez-Hess; Julia Dolores Toscano-Garibay; Luis Marat Alvarez-Salas
Journal:  Nucleic Acid Ther       Date:  2014-08-11       Impact factor: 5.486

Review 2.  Aptamer-Functionalized Nanoparticles as "Smart Bombs": The Unrealized Potential for Personalized Medicine and Targeted Cancer Treatment.

Authors:  Gregory Benedetto; C Greer Vestal; Christine Richardson
Journal:  Target Oncol       Date:  2015-12       Impact factor: 4.493

3.  The Subcellular Localisation of the Human Papillomavirus (HPV) 16 E7 Protein in Cervical Cancer Cells and Its Perturbation by RNA Aptamers.

Authors:  Özlem Cesur; Clare Nicol; Helen Groves; Jamel Mankouri; George Eric Blair; Nicola J Stonehouse
Journal:  Viruses       Date:  2015-06-26       Impact factor: 5.048

4.  An RNA Aptamer Targets the PDZ-Binding Motif of the HPV16 E6 Oncoprotein.

Authors:  Tamara A Belyaeva; Clare Nicol; Ozlem Cesur; Gilles Travé; George Eric Blair; Nicola J Stonehouse
Journal:  Cancers (Basel)       Date:  2014-07-24       Impact factor: 6.639

Review 5.  Aptamers for Anti-Viral Therapeutics and Diagnostics.

Authors:  Tae-Hyeong Kim; Seong-Wook Lee
Journal:  Int J Mol Sci       Date:  2021-04-17       Impact factor: 5.923

Review 6.  Advances in Screening and Development of Therapeutic Aptamers Against Cancer Cells.

Authors:  Zheng Li; Xuekun Fu; Jie Huang; Peiyuan Zeng; Yuhong Huang; Xinxin Chen; Chao Liang
Journal:  Front Cell Dev Biol       Date:  2021-05-19

7.  An RNA aptamer provides a novel approach for the induction of apoptosis by targeting the HPV16 E7 oncoprotein.

Authors:  Clare Nicol; Özlem Cesur; Sophie Forrest; Tamara A Belyaeva; David H J Bunka; G Eric Blair; Nicola J Stonehouse
Journal:  PLoS One       Date:  2013-05-30       Impact factor: 3.240

8.  Aptamer-based therapeutics: new approaches to combat human viral diseases.

Authors:  Ka-To Shum; Jiehua Zhou; John J Rossi
Journal:  Pharmaceuticals (Basel)       Date:  2013-11-25

Review 9.  Oligonucleotide aptamers: promising and powerful diagnostic and therapeutic tools for infectious diseases.

Authors:  Qin Pan; Fengling Luo; Min Liu; Xiao-Lian Zhang
Journal:  J Infect       Date:  2018-05-07       Impact factor: 6.072

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.